• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

股腘动脉疾病患者中性粒细胞与淋巴细胞比值与药物涂层球囊再狭窄的关系

Relationship Between Neutrophil-Lymphocyte Ratio and Drug-Coated Balloon Restenosis in Patients With Femoropopliteal Arterial Disease.

作者信息

Pan Tao, Tian Shi-Yun, Liu Zhen, Zhang Tao, Li Cheng, Ji Dong-Hua, Wang Feng

机构信息

Department of the Interventional Therapy, 74710First Affiliated Hospital of Dalian Medical University, Dalian, China.

Department of Radiology, 74710First Affiliated Hospital of Dalian Medical University, Dalian, China.

出版信息

Angiology. 2023 Mar;74(3):252-258. doi: 10.1177/00033197221102222. Epub 2022 May 14.

DOI:10.1177/00033197221102222
PMID:35575010
Abstract

We investigated the relationship between neutrophil-lymphocyte ratio (NLR) and restenosis in patients with femoropopliteal arterial disease following drug-coated balloon (DCB) angioplasty. Patients (n = 120) were divided into 3 groups according to the development of restenosis and the time of restenosis occurrence. The postoperative NLR was higher in the late-restenosis group than that in the no-restenosis group (3.53 vs 2.70; = .011). In multivariate logistic analysis, postoperative NLR was an independent predictor of late restenosis (odds ratio: 1.404, 95% confidence interval: 1.073-1.839; = .014). The postoperative NLR cutoff value for predicting late restenosis was 2.78 with a sensitivity of 80.8% and a specificity of 53.2% (area under the ROC curve was .666 (95% CI: .541-.791, = .010). The incidence of late restenosis in the NLR ≥2.78 group was higher than that in the NLR <2.78 group (32.3 vs 9.1%; = .002). Postoperative NLR is independently associated with late restenosis in patients treated with DCB for femoropopliteal arterial disease.

摘要

我们研究了股腘动脉疾病患者在药物涂层球囊(DCB)血管成形术后中性粒细胞与淋巴细胞比值(NLR)与再狭窄之间的关系。根据再狭窄的发生情况和再狭窄出现的时间,将120例患者分为3组。晚期再狭窄组术后NLR高于无再狭窄组(3.53对2.70;P = 0.011)。在多因素逻辑回归分析中,术后NLR是晚期再狭窄的独立预测因素(比值比:1.404,95%置信区间:1.073 - 1.839;P = 0.014)。预测晚期再狭窄的术后NLR临界值为2.78,敏感性为80.8%,特异性为53.2%(ROC曲线下面积为0.666(95%CI:0.541 - 0.791,P = 0.010)。NLR≥2.78组晚期再狭窄的发生率高于NLR<2.78组(32.3%对9.1%;P = 0.002)。对于接受DCB治疗的股腘动脉疾病患者,术后NLR与晚期再狭窄独立相关。

相似文献

1
Relationship Between Neutrophil-Lymphocyte Ratio and Drug-Coated Balloon Restenosis in Patients With Femoropopliteal Arterial Disease.股腘动脉疾病患者中性粒细胞与淋巴细胞比值与药物涂层球囊再狭窄的关系
Angiology. 2023 Mar;74(3):252-258. doi: 10.1177/00033197221102222. Epub 2022 May 14.
2
Relationship Between Postoperative Neutrophil-Lymphocyte Ratio and 6-Month Primary Patency of Percutaneous Transluminal Angioplasty in Femoropopliteal disease With Drug-Coated and Uncoated Balloons.股腘动脉病变药物涂层球囊与非涂层球囊经皮腔内血管成形术后中性粒细胞与淋巴细胞比值与 6 个月一期通畅率的关系
Angiology. 2019 Mar;70(3):244-248. doi: 10.1177/0003319718799589. Epub 2018 Sep 16.
3
Anemia as a risk factor for restenosis in femoropopliteal arterial disease after drug-coated balloon angioplasty.贫血作为药物涂层球囊血管成形术后股腘动脉疾病再狭窄的一个危险因素。
Vascular. 2023 Oct;31(5):948-953. doi: 10.1177/17085381221098289. Epub 2022 May 1.
4
Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.激光动脉粥样切除术和药物涂层球囊治疗股腘段支架内再狭窄:2 年结果。
Catheter Cardiovasc Interv. 2020 Feb 15;95(3):439-446. doi: 10.1002/ccd.28636. Epub 2019 Dec 9.
5
The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.LEVANT I 试验(卢特利克斯紫杉醇涂层球囊用于预防股腘动脉再狭窄):首例人体股腘动脉血运重建的低剂量药物涂层球囊与非涂层球囊血管成形术的随机试验。
JACC Cardiovasc Interv. 2014 Jan;7(1):10-9. doi: 10.1016/j.jcin.2013.05.022.
6
Determinants of Drug-Coated Balloon Failure in Patients Undergoing Femoropopliteal Arterial Intervention.股腘动脉介入治疗患者中药物涂层球囊失败的决定因素。
J Am Coll Cardiol. 2022 Sep 27;80(13):1241-1250. doi: 10.1016/j.jacc.2022.06.043.
7
Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.药物涂层球囊血管成形术与普通球囊血管成形术治疗股腘动脉疾病的系统评价和更新的荟萃分析。
J Vasc Surg. 2019 Sep;70(3):981-995.e10. doi: 10.1016/j.jvs.2019.01.080. Epub 2019 May 21.
8
The Relationship Between the Neutrophil-Lymphocyte Ratio and In-Stent Restenosis in Patients With Femoropopliteal Chronic Total Occlusions.股腘动脉慢性完全闭塞患者中性粒细胞与淋巴细胞比值与支架内再狭窄的关系
Angiology. 2018 Feb;69(2):177-182. doi: 10.1177/0003319717714918. Epub 2017 Jun 21.
9
Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease.紫杉醇涂层球囊血管成形术治疗股腘外周动脉疾病的安全性。
JACC Cardiovasc Interv. 2019 Dec 23;12(24):2515-2524. doi: 10.1016/j.jcin.2019.08.025. Epub 2019 Sep 28.
10
Diabetes mellitus and femoropopliteal in-stent restenosis.糖尿病与股腘动脉支架内再狭窄。
Vasa. 2022 Jul;51(4):247-255. doi: 10.1024/0301-1526/a001006. Epub 2022 May 11.

引用本文的文献

1
Neutrophil-to-lymphocyte ratio as a potential biomarker in predicting in-stent restenosis: A systematic review and meta-analysis.中性粒细胞与淋巴细胞比值作为预测支架内再狭窄的潜在生物标志物:一项系统评价和荟萃分析。
PLoS One. 2025 May 16;20(5):e0322461. doi: 10.1371/journal.pone.0322461. eCollection 2025.
2
Inflammatory-Related Biomarkers in Patients Undergoing Percutaneous Transluminal Angioplasty for Femoropopliteal Artery Lesions.接受股腘动脉病变经皮腔内血管成形术患者的炎症相关生物标志物
Acta Cardiol Sin. 2025 Jan;41(1):138-147. doi: 10.6515/ACS.202501_41(1).20241024A.
3
A systematic review of clinical and biomechanical engineering perspectives on the prediction of restenosis in coronary and peripheral arteries.
冠状动脉和外周动脉再狭窄预测的临床与生物力学工程视角的系统综述。
JVS Vasc Sci. 2023 Sep 15;4:100128. doi: 10.1016/j.jvssci.2023.100128. eCollection 2023.